Annual Secretarial Compliance
Awaiting price reaction for this filing.
J. B. Chemicals & Pharmaceuticals has submitted its annual Secretarial Compliance Certificate as required under SEBI's Listing Regulations. Practicing Company Secretary Ashish Bhatt & Associates reviewed the company's compliance across 12 areas covering secretarial standards, policies, website disclosures, director eligibility, subsidiary management, document preservation, board evaluations, related party transactions, event disclosures, insider trading, and SEBI actions. The company was found compliant in all areas except one minor issue: a delay in appointing Mr. Arun Duggal (age 77) as a Non-executive Independent Director via postal ballot concluded on July 5, 2024, which led to a delay in complying with Regulation 17(1) of the listing rules. No fines were imposed, no SEBI or stock exchange actions were taken against the company, and there were no auditor resignations during the year.
This is a routine annual regulatory filing with no material impact on shareholders. The single flagged non-compliance regarding a director appointment delay is minor and carries no penalty. Investors can take comfort from a clean compliance record across all major SEBI regulations for FY25.